doi: 10.2164/jandrol.107.004416 60 DobrzyskaMMBaumgartnerAAndersonD
This nicotinamide/ribose stack was shown in a clinical study at the University of Washington to significantly lower salivary cortisol in healthy middle-aged adults
Cenci A, Macchia I, La Sorsa V, Sbarigia C, Di Donna V, Pietraforte D
This guide covers the options with the most clinical evidence in each camp, and what each is best suited to
In the field of delivery technology, targeting the unique joint anatomy and pathological environment of OA, developing biodegradable sustained-release carriers such as smart responsive nanogels, porous microspheres, or tissue engineering scaffolds is key to achieving long-term and controlled release of GPX4 genes, regulatory miRNAs or ASOs, or small molecule ferroptosis inhibitors at the lesion site (Wang Y